why choose us

First received: January 30, 2023

Clinical Trial: A GBT021601 ADME Microtracer Study in Healthy Volunteers

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Sickle Cell Disease

Study Type: Interventional


Official Title: A Phase 1 Study To Assess the Mass Balance, Excretion, and Pharmacokinetics of [14C]-GBT021601, An Oral Hemoglobin S Polymerization Inhibitor, in Healthy Participants

Brief Summary: An Open-label Study of GBT021601 in 8 to 10 healthy male or female participants to evaluate the absorption, distribution, metabolism, and excretion (ADME) of GBT021601.

Read more